NICE says to restrict antibiotics in COPD

NICE says to restrict antibiotics in COPD

July 13 2018 Draft guidance is calling for health professionals to consider the risk of...

NICE updates guideline on rheumatoid arthritis

NICE updates guideline on rheumatoid arthritis

July 13 2018 NICE has issued a new version of its guideline on the management of rheumatoid...

Community pharmacy option for antihypertensives referral sees little increase in GP workload

Community pharmacy option for antihypertensives referral sees little increase in GP workload

July 11 2018 Community pharmacy referrals for hypertensive patients under the New Medicines...

CMO concludes cannabis products should move out of Schedule 1 classification

CMO concludes cannabis products should move out of Schedule 1 classification

July 9 2018 The Chief Medical Officer has recommended rescheduling cannabis-based products as...

GP partnership review invites views on how to reinvigorate the model

GP partnership review invites views on how to reinvigorate the model

July 6 2018 The Department of Health and Social Care has set out the lines of inquiry for the...

  • NICE says to restrict antibiotics in COPD

    NICE says to restrict antibiotics in COPD

    Friday, 13 July 2018 13:05
  • NICE updates guideline on rheumatoid arthritis

    NICE updates guideline on rheumatoid arthritis

    Friday, 13 July 2018 12:58
  • Community pharmacy option for antihypertensives referral sees little increase in GP workload

    Community pharmacy option for antihypertensives referral sees little increase in GP workload

    Wednesday, 11 July 2018 13:17
  • CMO concludes cannabis products should move out of Schedule 1 classification

    CMO concludes cannabis products should move out of Schedule 1 classification

    Monday, 09 July 2018 09:26
  • GP partnership review invites views on how to reinvigorate the model

    GP partnership review invites views on how to reinvigorate the model

    Friday, 06 July 2018 15:17

a rheum arthritis imageJuly 13 2018

NICE has issued a new version of its guideline on the management of rheumatoid arthritis (RA), updating guidance from 2009 and the 2015 revisions.

Among the new recommendations in NICE guideline NG 100 are sections on: 

  • investigation after establishing a diagnosis of RA;
  • the treat-to-target strategy;
  • conventional disease-modifying anti-rheumatic drugs;
  • symptom control including use of oral non-steroidal anti-inflammatory drugs and factors to consider with NSAIDs;
  • monitoring of patients and frequency of review.

In addition to the above, there have been some amendments to existing guidance, as well as some changes without an evidence review to:

  • clarify when urgent referral is needed;
  • clarify when measuring anti-cyclic citrullinated peptide antibodies might be considered for diagnosis;
  • clarify that X-ray of the hands and feet applies to adults with suspected rheumatoid arthritis (RA);
  • clarify that other treatments rather than analgesics should be considered for people on low-dose aspirin (analgesics other than NSAIDs are no longer recommended);
  • clarify that all adults with RA should have an annual review, including those who have reached their treatment target.

Links:
NICE guideline NG 100: ‘Rheumatoid arthritis in adults: management’. July 2018

Among the new recommendations in NICE guideline NG 100 are sections on: 

  • investigation after establishing a diagnosis of RA;
  • the treat-to-target strategy;
  • conventional disease-modifying anti-rheumatic drugs;
  • symptom control including use of oral non-steroidal anti-inflammatory drugs and factors to consider with NSAIDs;
  • monitoring of patients and frequency of review.

In addition to the above, there have been some amendments to existing guidance, as well as some changes without an evidence review to:

  • clarify when urgent referral is needed;
  • clarify when measuring anti-cyclic citrullinated peptide antibodies might be considered for diagnosis;
  • clarify that X-ray of the hands and feet applies to adults with suspected rheumatoid arthritis (RA);
  • clarify that other treatments rather than analgesics should be considered for people on low-dose aspirin (analgesics other than NSAIDs are no longer recommended);
  • clarify that all adults with RA should have an annual review, including those who have reached their treatment target.

Links:

NICE guideline NG 100: ‘Rheumatoid arthritis in adults: management’. July 2018 

Professional News

July 13 2018 Draft guidance is calling for health professionals to consider the risk of antimicrobial resistance when prescribing for chronic obstructive pulmonary disease (COPD).
July 11 2018 Community pharmacy referrals for hypertensive patients under the New Medicines Service has not increased GP workload appreciably. Analysis of 131,419 patient records in England has...